Tyrosine Kinases as Targets for Cancer Therapy
Daniela S. Krause(German Cancer Research Center), Richard A. Van Etten(University of California, Irvine)
Cited by 1,378
Related Papers
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
|The Journal of Experimental Medicine|2020|145
Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3